Results in Terns leukemia drug study suggest it could be a successor to Novartis blockbuster TERN-701 has garnered considerable attention for its potential to be superior to Novartis’ Scemblix

https://www.statnews.com/2025/12/08/terns-leukemia-drug-ash-results-tern-701/ By Adam FeuersteinDec. 8, 2025 Senior Writer, Biotech